Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006009
Recruitment Status : Completed
First Posted : October 8, 2003
Last Update Posted : May 15, 2013
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Actual Study Completion Date : October 2003